Tang Capital Management LLC Relmada Therapeutics, Inc. Transaction History

Tang Capital Management LLC

$1.33 Billion
Q4 2024

A detailed history of Tang Capital Management LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 200,825 shares of RLMD stock, worth $60,247. This represents 0.01% of its overall portfolio holdings.

Number of Shares

200,825

Previous 50,825 295.13%

Holding current value

$60,247

Previous $164,000 36.59%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.35 - $3.65 $52,500 - $547,500	150,000 Added 295.13%	200,825 $104,000
Q3 2024 Nov 14, 2024	SELL	$2.3 - $4.36 $430,212 - $815,533	-187,049 Reduced 78.63%	50,825 $164,000
Q2 2024 Aug 14, 2024	BUY	$2.93 - $4.94 $695,851 - $1.17 Million	237,492 Added 62170.68%	237,874 $713,000
Q1 2024 May 15, 2024	BUY	$3.1 - $6.8 $1,184 - $2,597	382 New	382 $1,000
Q4 2022 Feb 14, 2023	SELL	$2.17 - $35.84 $651,000 - $10.8 Million	-300,000 Reduced 75.0%	100,000 $349,000
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $6.6 Million - $12.1 Million	400,000 New	400,000 $7.6 Million
Q1 2022 May 16, 2022	SELL	$16.72 - $26.99 $988,519 - $1.6 Million	-59,122 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.93 - $26.82 $692,064 - $1.1 Million	-40,878 Reduced 40.88%	59,122 $1.33 Million
Q2 2021 Aug 16, 2021	SELL	$29.55 - $39.15 $2.96 Million - $3.92 Million	-100,000 Reduced 50.0%	100,000 $3.2 Million
Q4 2020 Feb 16, 2021	SELL	$29.88 - $39.8 $8.96 Million - $11.9 Million	-300,000 Reduced 60.0%	200,000 $6.41 Million
Q2 2020 Aug 14, 2020	SELL	$31.59 - $49.98 $25.3 Million - $40 Million	-800,000 Reduced 61.54%	500,000 $22.4 Million
Q4 2019 Feb 14, 2020	BUY	$10.1 - $47.18 $13.1 Million - $61.3 Million	1,300,000 New	1,300,000 $50.7 Million

Others Institutions Holding RLMD

# of Institutions

Shares Held

8.32M

Call Options Held

364K

Put Options Held

46.5K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $8.58M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Account

Tang Capital Management LLC Relmada Therapeutics, Inc. Transaction History